Senior Scientist, SickKids Research Institute, The Hospital for Sick Children
Associate Professor, Biochemistry and Immunology, UofT
Canada Research Chair, Structural Immunology
Prof. Julien holds the Canada Research Chair in Structural Immunology, and is a Member of the College of the Royal Society of Canada and a CIFAR Global Scholar. He has broad experience in characterizing antibody-antigen interactions using biophysical and molecular biology methods. Prof. Julien is a leader in the development of innovative antibody therapeutics and vaccines from molecular blueprints, including recent success targeting SARS-CoV-2, HIV-1 and malaria, and helps to coordinate EPIC’s vaccine and immunotherapy approaches.
Related links
- SickKids scientist Dr. Jean-Philippe Julien named one of Canada’s Top 40 Under 40. 18 November, 2021.
- SickKids researchers develop promising ‘super molecule’ that boosts viral neutralization against COVID-19. 16 June, 2021.
- How AI is enabling COVID-19 research. 17 July, 2020.
- Video: Jean-Philippe Julien: 2019 Royal Society of Canada’s College of New Scholars, Artists and Scientists. 23 November, 2019.